ECCO 2017 | ECCO 2017: treatment value vs affordability

Bettina Ryll, MD, PhD from the Melanoma Patient Network Europe discusses value vs affordability of treatment at the European Cancer Congress of the European Cancer Organisation (ECCO) 2017 in Amsterdam, Netherlands. A key topic at this conference is the debate of a drugs value vs its affordability. Melanoma patients depend on innovative therapies for survival. She states that there is a large difference in survival between patients in countries that have access to these drugs, and ones that don’t, and this is a point that has to be further discussed.